GLP-1 drugs for diabetes and weight loss are difficult for some people to inject weekly. A new slow-release gel, tested in rats, could help.

Inhaled insulin is effective for controlling blood sugar levels in children with diabetes, providing them with a ...

Type 1 and type 2 diabetes are driven by very different mechanisms. In type 2 , cells in the pancreas that make insulin become less sensitive to blood sugar and produce less insulin in response.

Sold under the trade names such as Ozempic, Wegovy and Rybelsus, ... While semaglutide is already approved for Type 2 diabetes and obesity, its use in Type 1 diabetes remains investigational.

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

Type 1 and type 2 diabetes are driven by very different mechanisms. In type 2 , cells in the pancreas that make insulin become less sensitive to blood sugar and produce less insulin in response.

GLP-1 agonists, including liraglutide, are typically used to control blood sugar levels in type 2 diabetes and to promote weight loss. These drugs mimic a hormone released after eating, helping to ...

CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed. In this 26-week, double-blind trial of 72 adults, 36% ...

Adults with type 1 diabetes had a greater reduction in HbA1c and improvement in time in range with semaglutide than placebo. ... (Ozempic, Novo Nordisk) or placebo. Viral N. Shah.

What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...